• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bio-Works Technologies AB: Bio-Works Receives Two WorkBeads 100S and 100Q Orders Worth SEK 4 Million

BIOWKSRegulatory press release29.12.2025, 08.00
Download the release

Bio-Works Technologies AB has received two orders from a recurring customer in India for WorkBeads 100S and WorkBeads 100Q. The total order value amounts to approximately SEK 4 million.

The deliveries are scheduled for Q1-Q2 2026 and strengthen the company's order book for the coming year.

The orders confirm the growing demand for Bio-Works' scalable and cost-efficient affinity solutions for biopharmaceutical manufacturing.

"This transaction demonstrates both the strength of our long-term customer relationships and the increasing global demand for our WorkBeads products. It supports our planned growth and aligns well with our ambition to build a profitable and scalable Bio-Works," says Lone Carlbom, CEO of Bio-Works.

This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">29-12-2025 08:00 CET.